SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vasomedical Inc.
VASO 0.1550.0%3:25 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: SG who wrote (844)1/30/1998 11:44:00 PM
From: DrJerry  Read Replies (1) of 1605
 
To SG: If the posters on this thread really did their
homework and contacted users of Vaso's EECP device
instead of arriving at conclusions based on supposition
then we would all be better off. In my conversations
I have not spoken with one user who is: (a) sorry he
has dealt with Vaso and (b) would not recommend it to
other users. DONT FORGET: Major universities and centers
are now advocates based on the MUST trial. Vaso's marketing strategies suggest that holding out for more
significant dollars/unit will ultimately benefit the
stockholders. Most centers are collecting dollars from
their patients. In NJ, at least 5 managed care companies
have paid 6-8K per treatment course. This information may
be obtained by conatacting centers which are operational.
Soooooo- let us be thorough in our homework and patient
with stock movement.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext